
    
      This study is designed to evaluate the effectiveness of nasal glucagon (NG) administered
      under clinical use conditions in treating episodes of moderate or severe hypoglycemia in
      persons with T1D.

      This study also aims to assess the ease with which caregivers can administer the experimental
      medication in treatment of hypoglycemic events.
    
  